Episode Details
Back to Episodes
In the News... the "Next Ozempic" moves forward, diabetes and dementia link, tech updates & approvals, ATTD news and more
Description
It's In the News, a look at the top headlines and stories in the diabetes community.
This week's top stories: Metformin may help stem macular degeneration, retatutride moves forward, T1D and demntia link studied, lots of news from ATTD and more!
Announcing Community Commericals! Learn how to get your message on the show here.
Learn more about studies and research at Thrivable here
Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com
transcript with links:
Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes.
Who's in Vegas? I'll see you there at the Breakthrough T1D summit this weekend.
And we have two Club 1921 events for health care providers and patient leaders happening in April – head on over to the website for more.
Okay.. our top story this week:
XX
Metformin may be linked to the slower progression of age-related macular degeneration (AMD). Among people with diabetes who were older than 55, those taking metformin had a 37% lower chance of developing intermediate AMD over a five-year period compared with individuals who were not using the medication.
It's one of the leading causes of vision loss in the US and many other western countries.
These researchers now say a clinical trial is the next step.
https://scitechdaily.com/scientists-discover-surprising-eye-benefit-of-widely-used-diabetes-drug/
XX
new study suggests people with type 1 diabetes may be nearly three times as likely to develop dementia compared with people without diabetes.
Similarly, people with type 2 diabetes may have roughly twice the risk of dementia compared with those without diabetes.
However, the study found an association rather than proof of causation, meaning diabetes was linked to dementia risk but was not shown to directly cause it.
XX
Researchers in Japan say they've developed an insulin pill… in mice. The study, published in the journal Molecular Pharmace